학술논문
Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755